Hoyos, C.; Fontaine, A.; Jacques, J.-R.; Heinen, V.; Louis, R.; Duysinx, B.; Scherpereel, A.; Wasielewski, E.; Jamakhani, M.; Hamaidia, M.;
et al. HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells. Cancers 2022, 14, 2164.
https://doi.org/10.3390/cancers14092164
AMA Style
Hoyos C, Fontaine A, Jacques J-R, Heinen V, Louis R, Duysinx B, Scherpereel A, Wasielewski E, Jamakhani M, Hamaidia M,
et al. HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells. Cancers. 2022; 14(9):2164.
https://doi.org/10.3390/cancers14092164
Chicago/Turabian Style
Hoyos, Clotilde, Alexis Fontaine, Jean-Rock Jacques, Vincent Heinen, Renaud Louis, Bernard Duysinx, Arnaud Scherpereel, Eric Wasielewski, Majeed Jamakhani, Malik Hamaidia,
and et al. 2022. "HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells" Cancers 14, no. 9: 2164.
https://doi.org/10.3390/cancers14092164
APA Style
Hoyos, C., Fontaine, A., Jacques, J.-R., Heinen, V., Louis, R., Duysinx, B., Scherpereel, A., Wasielewski, E., Jamakhani, M., Hamaidia, M., & Willems, L.
(2022). HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells. Cancers, 14(9), 2164.
https://doi.org/10.3390/cancers14092164